Menstrual cycle
The menstrual cycle plays a role in the variation of symptoms and symptom severity in many immunological, neurological, and female predominant diseases.
Cycles and phases[edit | edit source]
Ovarian cycle[edit | edit source]
Follicular phase[edit | edit source]
Ovulation[edit | edit source]
Luteal phase[edit | edit source]
Uterine cycle[edit | edit source]
Menstruation[edit | edit source]
Proliferative phase[edit | edit source]
Secretory phase[edit | edit source]
Immune changes[edit | edit source]
Populations of Tregs increase peak just before ovulation and bottom out during the luteal phase, just before menstruation.
Progesterone and estrogen have anti-inflammatory effects.
Health effects in ME/CFS[edit | edit source]
Women who develop CFS report at higher rates a history of irregular cycles, amenorrhea, anovolutory cycles and sporadic bleeding between periods.[1]
Health effects in other conditions[edit | edit source]
The menstrual cycle can have effects on the timing and severity of symptoms of women suffering from many different conditions, including epilepsy, migraines, asthma, rheumatoid arthritis and irritable bowel syndrome.[2]
Many women with epilepsy have patterns of seizure activity linked to their menstrual cycles, called catamenial epilepsy.[3][4][5][6] Seizure activity increases just before ovulation and just before menstruation.[7]
Abrupt estrogen withdrawal, such as what occurs just prior to menstruation, can trigger migraines.[8][9] Women with rheumatoid arthritis experienced reduced symptoms after ovulation, owing potentially to the anti-inflammatory effects of progesterone and estrogen.[10]
In a retrospective study, 72% of women with fibromyalgia reported a worsening of symptoms just before their periods.[11]
Women with these diseases may experiencing a worsening of symptoms at specific points in their menstrual cycle, particularly just before or around their periods.[12]
Managing premenstrual symptoms[edit | edit source]
Nonsteroidal anti-inflammatory agents are occasionally effective in women with menstrual migraine, as are beta blockers, calcium channel blockers, ergotamine, antidepressants, estrogen and estradiol.[13]
Pathophysiology of menstrual symptoms[edit | edit source]
Estrogen may directly affect blood vessels by stimulating nitric oxide release. Women with a history of menstrual migraine had a heightened activation of the nitro oxide and L-arginine pathways, especially during the luteal phase.[14]
See also[edit | edit source]
References[edit | edit source]
- ↑ http://www.amjmed.com/article/S0002-9343(98)00173-9/abstract
- ↑ http://archinte.jamanetwork.com/article.aspx?articleid=208109
- ↑ http://www.seizure-journal.com/article/S1059-1311(07)00233-6/abstract
- ↑ http://onlinelibrary.wiley.com/doi/10.1002/ana.20214/abstract;jsessionid=6C4279A672141BB3D4C3A2C30AD44751.f01t04
- ↑ http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1157.1997.tb01197.x/abstract
- ↑ http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2006.00672.x/abstract
- ↑ http://archinte.jamanetwork.com/article.aspx?articleid=208109
- ↑ http://jama.jamanetwork.com/article.aspx?articleid=202685
- ↑ http://archinte.jamanetwork.com/article.aspx?articleid=208109
- ↑ http://www.amjmed.com/article/0002-9343(83)90789-1/abstract
- ↑ http://www.tandfonline.com/doi/abs/10.3109/03009749709065698
- ↑ Zierau, Oliver (2012). "Role of female sex hormones, estradiol and progesterone, in mast cell behavior". Front Immunol.
- ↑ http://archinte.jamanetwork.com/article.aspx?articleid=208109
- ↑ http://jama.jamanetwork.com/article.aspx?articleid=202685